HomeROQ • LON
add
Roquefort Therapeutics PLC
Previous close
GBX 4.40
Day range
GBX 4.30 - GBX 4.50
Year range
GBX 3.85 - GBX 9.50
Market cap
5.81M GBP
Avg Volume
533.61K
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
(GBP) | Jun 2023info | Y/Y change |
---|---|---|
Revenue | 100.00K | — |
Operating expense | 568.72K | 49.21% |
Net income | -391.18K | -2.63% |
Net profit margin | -391.18 | — |
Earnings per share | — | — |
EBITDA | -468.12K | -52.90% |
Effective tax rate | 16.54% | — |
Balance Sheet
Total assets
Total liabilities
(GBP) | Jun 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.38M | -58.57% |
Total assets | 7.12M | 49.65% |
Total liabilities | 652.21K | -52.61% |
Total equity | 6.47M | — |
Shares outstanding | 129.15M | — |
Price to book | 0.88 | — |
Return on assets | -16.45% | — |
Return on capital | -18.11% | — |
Cash Flow
Net change in cash
(GBP) | Jun 2023info | Y/Y change |
---|---|---|
Net income | -391.18K | -2.63% |
Cash from operations | -444.26K | -163.38% |
Cash from investing | -27.02K | — |
Cash from financing | — | — |
Net change in cash | -471.98K | -138.86% |
Free cash flow | -316.78K | -135.55% |
About
Founded
2020
Website
Employees
9